# An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime

> **NCT01487421** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 2134 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin aspart
- **DRUG:** insulin detemir

## Key facts

- **NCT ID:** NCT01487421
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 2134 (ACTUAL)
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01487421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01487421, "An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01487421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*